| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
| Medtronic plc | $105.2b | $76.40 | -0.7% | 9.1M | |
| Edwards Lifesciences Corp | $47.4b | $81.38 | +0.0% | 4.7M | |
| Alcon Inc. Ordinary Shares | $36.8b | $63.64 | -0.6% | 2.1M | |
| Biogen Inc. Common Stock | $26.9b | $192.85 | +0.8% | 1.3M | |
| Zimmer Biomet Holdings, Inc. | $16.0b | $83.70 | +1.3% | 2.6M | |
| Glaukos Corporation | $7.0b | $144.01 | +1.3% | 978.7K | |
| Bausch + Lomb Corporation | $5.6b | $16.09 | -1.1% | 450.9K | |
| Denali Therapeutics Inc. Common Stock | $3.2b | $18.63 | -3.9% | 2.2M | |
| BioAge Labs, Inc. Common Stock | $0.8b | $17.65 | -5.7% | 481.6K | |
| Bioventus Inc. Class A Common Stock | $0.7b | $10.56 | -0.5% | 710.4K | |
| Anteris Technologies Global Corp. Common Stock | $0.6b | $7.25 | 0.0% | 1.0M | |
| AC Immune SA | $308.4m | $2.79 | -0.2% | 357.2K | |
| LENZ Therapeutics, Inc. Common Stock | $291.3m | $7.33 | +0.5% | 994.3K | |
| Alector, Inc. Common Stock | $263.8m | $2.17 | -5.7% | 1.1M | |
| Acumen Pharmaceuticals, Inc. Common Stock | $177.7m | $2.27 | -5.0% | 390.2K | |
| Alpha Cognition Inc. Common Stock | $135.0m | $6.16 | +8.4% | 96.1K | |
| Cognition Therapeutics, Inc. Common Stock | $114.4m | $1.15 | -4.6% | 765.6K | |
| Telomir Pharmaceuticals, Inc. Common Stock | $99.7m | $1.26 | -0.8% | 79.3K | |
| Annovis Bio, Inc. | $63.9m | $2.06 | -3.3% | 854.6K | |
| Greenland Mines Ltd. Common Stock | $54.7m | $0.39 | +1.9% | 2.5M | |
| Envoy Medical, Inc. Class A Common Stock | $48.8m | $0.65 | -2.0% | 59.6K | |
| CervoMed Inc. Common Stock | $34.3m | $3.49 | -7.2% | 119.6K | |
| Outlook Therapeutics, Inc. Common Stock | $31.6m | $0.23 | -2.7% | 2.7M | |
| NeuroSense Therapeutics Ltd. Ordinary Shares | $28.6m | $0.83 | -2.6% | 43.4K | |
| Longeveron Inc. Common Stock | $25.9m | $0.67 | -4.6% | 878.0K | |
| OSR Holdings, Inc. Common Stock | $24.7m | $0.57 | -4.7% | 1.2M | |
| 20/20 Biolabs, Inc. Common Stock | $16.2m | $1.30 | -5.8% | 104.2K | |
| FibroBiologics, Inc. Common Stock | $6.2m | $1.04 | -3.2% | 122.2K | |
| Alzamend Neuro, Inc. Common Stock | $4.2m | $1.03 | +0.5% | 34.7K | |
| HCW Biologics Inc. Common Stock | $2.7m | $1.15 | +241.2% | 394.9M |